MedTrace Logo

Atrial Fibrillation Health Literacy and Information Technology Trial in Rural Pennsylvania Counties

NCT04076020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2024-05-30

Study results available
· View outcomes & findings →

Summary

Atrial fibrillation (AF) is a highly prevalent, morbid condition. Anticoagulation to prevent thromboembolic strokes is a foremost priority in AF but adherence is challenging for patients and lapses in anticoagulation are common. Chronic disease self-management (CDSM) is a recognized program to enhance self-efficacy and improve adherence, quality of life, and patient-centered health outcomes. Rural patients with AF experience increased vulnerability to adverse outcomes due to geographic and social isolation, poor health care access, and limited health literacy. This study uses an innovative, scalable CDSM intervention to improve anticoagulation adherence in rural patients with AF.

Conditions

  • Atrial Fibrillation
  • Familial Atrial Fibrillation
  • Arrhythmia, Cardiac
  • Heart Diseases
  • Pathologic Processes

Interventions

BEHAVIORAL

Relational agent/AliveCor Kardia - Intervention

Use of the relational agent and Kardia daily for 120 days.

BEHAVIORAL

Usual Care

Use of the WebMD app daily for 120 days.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Northeastern University

    collaborator OTHER

  • Boston University

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Jared W. Magnani, MD, MSc · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-08
Primary Completion
2023-05-27
Completion
2023-08-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04076020 on ClinicalTrials.gov